DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pegylated interferon
Pegylated interferon
Medical
Interplay Between Hepatitis D Virus and the Interferon Response
Estimating the Long-Term Clinical and Economic Outcomes of Daclatasvir
S Sofosbuvir (Sovaldi )
Pegasys®) Peginterferon Alfa-2B (Peg-Intron®
Combination of Entecavir Or Tenofovir with Pegylated Interferon
Nucleic Acid Polymers: Much-Needed Hope for Hepatitis D?
Original Article Randomized Study of Asunaprevir Plus Pegylated Interferon-Α and Ribavirin for Previously Untreated Genotype 1 Chronic Hepatitis C
Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies
EASL: GS‐7977, Daclatasvir, and Asunaprevir Look Good in Interferon‐Free Regimens for Hepatitis C
4 Activity Is Associated with Improved HCV Clearance and Reduced Expression of Interferon-Stimulated Genes
Interferon-Combination Strategies for the Treatment of Chronic Hepatitis C
PICO 6: Treatment Pegylated Interferon Plus Ribavirin Versus
And Ribavirin Oral Therapy for Treatment-Naive HCV Genotype 1: SOUND-C1 Final Results
Chronic Hepatitis D Virus Infection: Developing Drugs for Treatment Guidance for Industry
Pegasys, INN-Peginterferon Alfa-2A
DRUG NAME: Peginterferon Alfa-2A
Pegylated Interferon Alpha 2A
Top View
PEGASYS Prescribing Information
Update on PEG-Interferon Α-2B As Adjuvant Therapy in Melanoma
Pegasys (Peginterferon Alfa-2A) Label
Peginterferon Alfa-2A, Pegasys
Using Pegylated Interferon and Ribavirin to Treat Patients with Chronic Hepatitis C RAYMOND P
Treatment Direct Acting Antiviral Therapy Versus Pegylated
Product Monograph
SOVALDI (Sofosbuvir) Tablets, for Oral Use Symptomatic Bradycardia May Occur in Patients Taking Initial U.S
Interferon and Ribavirin for Treatment of Hepatitis C Virus Genotype 1 Infection
Treatment of Hepatitis C with Pegylated Interferon and Ribavirin, with Or Without Boceprevir Or Telaprevir
Original Article Treatment of Chronic Hepatitis D Patients with Pegylated Interferon: a Real-World Experience
Serum Asunaprevir and Daclatasvir Concentrations and Outcomes In
NATIONAL INSTITUTE for HEALTH and CLINICAL EXCELLENCE Final Appraisal Determination Adefovir Dipivoxil and Peginterferon Alfa-2A
Current and Future Management of Chronic Hepatitis D
Daclatasvir Plus Asunaprevir Dual Therapy for Chronic HCV Genotype 1B Infection
Side Effects of Peginterferon and Ribavirin Treatment for Hepatitis C and Their Management
Treatment of Chronic Hepatitis Delta with Pegylated Interferon-Α2b
Interferon-Based Combination Treatment for Chronic Hepatitis C in the Era of Direct Acting Antivirals
Peginterferon Alfa-2A (Pegasys®) EOCCO POLICY
Severe Stomatitis Complicating Treatment with Pegylated-Interferon ␣-2A and Ribavirin in an HCV-Infected Patient
Pegylated and Non-Pegylated Interferon Srx-0037 Policy Type ☒ Pharmacy ☐ Administrative ☐ Payment
Interferon Therapy – (1315)
Faldaprevir and Deleobuvir for HCV Genotype 1 Infection